T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia. 1993

K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
Department of Hematology, Harasanshin General Hospital, Fukuoka, Japan.

We describe 2 cases of "bilineal" crisis in chronic myelogenous leukemia (CML) with T cell and myeloid phenotypes. In both cases, morphocytochemically distinct myeloid and T lymphoid blast populations proliferated simultaneously in the phase of blastic crisis--myeloperoxidase (MPO)-positive, CD7+/CD33+ myeloblasts in the peripheral blood, and MPO-negative, periodic acid Schiff (PAS)-positive lymphoblasts in the lymph nodes. In each case, common karyotypes containing Ph1 translocation were demonstrated in both the peripheral blood and the lymph node samples. In Case 1, the lymph nodes were occupied by > 90% lymphoblasts, which were positive for CD2, cytoplasmic CD3 (cCD3), CD5 and CD7 and terminal deoxynucleotidyl transferase (TdT), but negative for myeloid antigens. Myeloblasts and T lymphoblasts showed an identical rearrangement of the bcr gene by Southern blotting analysis, although the clonal rearrangement of the T cell receptor (TcR)-delta gene was seen only in T lymphoblasts. In Case 2, simultaneous proliferation of myeloblasts and lymphoblasts was documented morphocytochemically in the lymph node, and a flow cytometric analysis revealed the coexistence of CD7+/CD33+ and CD7+/CD33- blast populations. Each blast population was enriched by antibody-conjugated immunomagnetic beads; the former was positive for MPO by 64% but negative for cCD3 and TdT, whereas the latter was positive for cCD3 and TdT but negative for MPO (< 1%). CD7+/CD33+ myeloblasts and CD7+/CD33- lymphoblasts showed an identical rearrangement of the bcr gene. Neither TcR-beta, TcR-gamma nor the TcR-delta gene was clonally rearranged in either population. These observations clearly indicate that T lymphoid and myeloid blasts share common Ph1-positive progenitors, and that Ph1-positive T lymphoid/myeloid progenitors are probably involved in the development of blastic transformation in some percentage of CML patients.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D001752 Blast Crisis An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%. Blast Phase,Blast Crises,Blast Phases,Crises, Blast,Crisis, Blast,Phase, Blast,Phases, Blast
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow

Related Publications

K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
February 1991, American journal of hematology,
K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
January 1984, Deutsche medizinische Wochenschrift (1946),
K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
January 2016, Indian journal of pathology & microbiology,
K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
December 1983, JAMA,
K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
January 2014, European journal of haematology,
K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
April 1985, Cancer genetics and cytogenetics,
K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
May 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
November 1985, Blood,
K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
December 2000, International journal of hematology,
K Akashi, and S Mizuno, and M Harada, and N Kimura, and M Kinjyo, and T Shibuya, and K Shimoda, and M Takeshita, and S Okamura, and I Matsumoto
January 2013, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society,
Copied contents to your clipboard!